Abstract:CYLD, a deubiquitinating enzyme (DUB), is a critical regulator of diverse cellular processes, ranging from proliferation and differentiation to inflammatory responses, via regulating multiple key signaling cascades such as nuclear factor kappa B (NF-κB) pathway. CYLD has been shown to inhibit vascular lesion formation presumably through suppressing NF-κB activity in vascular cells. However, herein we report a novel role of CYLD in mediating pro-inflammatory responses in vascular smooth muscle cells (VSMCs) via a mechanism independent of NF-κB activity. Adenoviral knockdown of Cyld inhibited basal and the tumor necrosis factor alpha (TNFα)-induced mRNA expression of pro-inflammatory cytokines including monocyte chemotactic protein-1 (Mcp-1), intercellular adhesion molecule (Icam-1) and interleukin-6 (Il-6) in rat adult aortic SMCs (RASMCs). The CYLD deficiency led to increases in the basal NF-κB transcriptional activity in RASMCs; however, did not affect the TNFα-induced NF-κB activity. Intriguingly, the TNFα-induced IκB phosphorylation was enhanced in the CYLD deficient RASMCs. While knocking down of Cyld decreased slightly the basal expression levels of IκBα and IκBβ proteins, it did not alter the kinetics of TNFα-induced IκB protein degradation in RASMCs. These results indicate that CYLD suppresses the basal NF-κB activity and TNFα-induced IκB kinase activation without affecting TNFα-induced NF-κB activity in VSMCs. In addition, knocking down of Cyld suppressed TNFα-induced activation of mitogen activated protein kinases (MAPKs) including extracellular signal-activated kinases (ERK), c-Jun N-terminal kinase (JNK), and p38 in RASMCs. TNFα-induced RASMC migration and monocyte adhesion to RASMCs were inhibited by the Cyld knockdown. Finally, immunochemical staining revealed a dramatic augment of CYLD expression in the injured coronary artery with neointimal hyperplasia. Taken together, our results uncover an unexpected role of CYLD in promoting inflammatory responses in VSMCs via a mechanism involving MAPK activation but independent of NF-κB activity, contributing to the pathogenesis of vascular disease.

CYLD Regulates Angiogenesis by Mediating Vascular Endothelial Cell Migration.

The Tumor Suppressor CYLD Regulates Microtubule Dynamics and Plays a Role in Cell Migration

Cytospin-A Regulates Colorectal Cancer Cell Division and Migration by Modulating Stability of Microtubules and Actin Filaments

CYLD coordinates with EB1 to regulate microtubule dynamics and cell migration.

A pro-inflammatory role of deubiquitinating enzyme cylindromatosis (CYLD) in vascular smooth muscle cells.

Endothelial CDS2 deficiency causes VEGFA-mediated vascular regression and tumor inhibition

CYLD Mediates Ciliogenesis in Multiple Organs by Deubiquitinating Cep70 and Inactivating HDAC6.

CYLD Negatively Regulates Hippo Signaling by Limiting Hpo Phosphorylation in Drosophila.

The Tumor Suppressor Cyld Controls Epithelial Morphogenesis and Homeostasis by Regulating Mitotic Spindle Behavior and Adherens Junction Assembly

CYLD Regulates RhoA Activity by Modulating LARG Ubiquitination.

[Inhibition of Proliferation and Migration of Human Umbilical Vein Endothelial Cells by Knockdown of Cylindromatosis (CYLD) Gene].

Tumor suppressor CYLD regulates JNK-induced cell death in Drosophila.

CYLD Deficiency Promotes Pancreatic Cancer Development by Causing Mitotic Defects

Tumour Suppressor Cyld is A Negative Regulator of the Mitotic Kinase Aurora-B

CYLD Regulates Spindle Orientation by Stabilizing Astral Microtubules and Promoting Dishevelled-Numa-dynein/dynactin Complex Formation

Cylindromatosis (CYLD), a Deubiquitinase, Attenuates Inflammatory Signaling Pathways by Activating Toll-Like Receptor 3 in Human Mesangial Cells

Regulation of angiogenesis by endocytic trafficking mediated by cytoplasmic dynein 1 light intermediate chain 1

Pro-angiogenic activities of CYR61 (CCN1) mediated through integrins alphavbeta3 and alpha6beta1 in human umbilical vein endothelial cells

DCBLD1 Modulates Angiogenesis by Regulation of the VEGFR-2 Endocytosis in Endothelial Cells

Potential Role for the Tumor Suppressor CYLD in Brain and Notochord Development.

Inactivation of Tumor Suppressor CYLD Inhibits Fibroblast Reprogramming to Pluripotency